Pharmacokinetic and Environmental Risk Assessment of Prime-2-CoV, a Non-Replicating Orf Virus-Based Vaccine against SARS-CoV-2

Metz, Carina; Haug, Verena; Mueller, Melanie; Amann, Ralf

dc.contributor.author	Metz, Carina
dc.contributor.author	Haug, Verena
dc.contributor.author	Amann, Ralf
dc.contributor.author	Müller, Melanie
dc.date.accessioned	2025-02-04T06:58:41Z
dc.date.available	2025-02-04T06:58:41Z
dc.date.issued	2024
dc.identifier.issn	2076-393X
dc.identifier.uri	http://hdl.handle.net/10900/161567
dc.language.iso	en	de_DE
dc.publisher	Basel : Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/vaccines12050492	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Pharmacokinetic and Environmental Risk Assessment of Prime-2-CoV, a Non-Replicating Orf Virus-Based Vaccine against SARS-CoV-2	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_01732
utue.personen.roh	Metz, Carina
utue.personen.roh	Haug, Verena
utue.personen.roh	Mueller, Melanie
utue.personen.roh	Amann, Ralf
dcterms.isPartOf.ZSTitelID	Vaccines	de_DE
dcterms.isPartOf.ZS-Issue	Article 492	de_DE
dcterms.isPartOf.ZS-Volume	12 (5)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE